Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

A study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Recruiting

2 1 1 1
Investigated Drugs:
A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

Recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
- SIGVOTATUG VEDOTIN
Comparing Sotorasib and Pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Recruiting

3 1 1 1
Investigated Drugs:
+11
A study to investigate the safety and effects of ceralasertib, tremelimumab, and durvalumab in adults with various solid tumors

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

Recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- HLX43
A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Recruiting

3 1 1
Investigated Drugs:
+2
A study of pembrolizumab, cetuximab, and MK-1084 for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations

Recruiting

2 1 1 1
Investigated Diseases:
- K-ras gene mutation
- Non-small cell lung cancer
Investigated Drugs:
A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Datopotamab Deruxtecan
- Docetaxel
+2
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

Recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- BNT327
Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
+3

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies